Avenir Wellness Solutions Past Earnings Performance
Past criteria checks 0/6
Avenir Wellness Solutions has been growing earnings at an average annual rate of 24.6%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 17.5% per year.
Key information
24.6%
Earnings growth rate
39.2%
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | 17.5% |
Return on equity | n/a |
Net Margin | -134.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Avenir Wellness Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 2 | -3 | 4 | 0 |
30 Jun 24 | 3 | -4 | 6 | 0 |
31 Mar 24 | 4 | -5 | 8 | 0 |
31 Dec 23 | 4 | -3 | 9 | 0 |
30 Sep 23 | 4 | -11 | 8 | 0 |
30 Jun 23 | 5 | -5 | 9 | 0 |
31 Mar 23 | 5 | -14 | 10 | 0 |
31 Dec 22 | 5 | -19 | 10 | 0 |
30 Sep 22 | 5 | -14 | 9 | 0 |
30 Jun 22 | 5 | -21 | 10 | 0 |
31 Mar 22 | 6 | -11 | 11 | -1 |
31 Dec 21 | 6 | -9 | 14 | 0 |
30 Sep 21 | 6 | -23 | 19 | 1 |
30 Jun 21 | 5 | -22 | 17 | 1 |
31 Mar 21 | 3 | -36 | 15 | 3 |
31 Dec 20 | 2 | -31 | 11 | 3 |
30 Sep 20 | 1 | -15 | 9 | 3 |
30 Jun 20 | 1 | -10 | 9 | 3 |
31 Mar 20 | 1 | -9 | 10 | 3 |
31 Dec 19 | 1 | -21 | 10 | 2 |
30 Sep 19 | 1 | -22 | 9 | 2 |
30 Jun 19 | 1 | -29 | 9 | 2 |
31 Mar 19 | 1 | -19 | 8 | 1 |
31 Dec 18 | 1 | -10 | 6 | 1 |
30 Sep 18 | 0 | -10 | 6 | 2 |
30 Jun 18 | 0 | -7 | 4 | 2 |
31 Mar 18 | 0 | -7 | 5 | 2 |
31 Dec 17 | 0 | -8 | 6 | 1 |
30 Sep 17 | 0 | -9 | 8 | 1 |
30 Jun 17 | 0 | -8 | 7 | 1 |
31 Mar 17 | 0 | -6 | 5 | 1 |
31 Dec 16 | 0 | -4 | 3 | 1 |
30 Sep 16 | 0 | -2 | 2 | 1 |
30 Jun 16 | 0 | -2 | 1 | 1 |
31 Mar 16 | 0 | -2 | 1 | 1 |
31 Dec 15 | 0 | -2 | 1 | 1 |
31 Dec 14 | 1 | -1 | 1 | 1 |
Quality Earnings: AVRW is currently unprofitable.
Growing Profit Margin: AVRW is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AVRW is unprofitable, but has reduced losses over the past 5 years at a rate of 24.6% per year.
Accelerating Growth: Unable to compare AVRW's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AVRW is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: AVRW's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.